[Ambulatory multicenter study of Triatec (ramipril). Observations concerning the lessons of the trial for the realization of future trials and for the management of hypertensive patients].
Battaglia
C
C
Service d'hypertension artérielle et médecine interne, hôpital Broussais, Paris.
Gallet
M
M
Carré
A
A
D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001643:Bridged Bicyclo Compounds / Q000627:therapeutic use*; D001952:Bridged-Ring Compounds / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods*; D005194:Family Practice; D005260:Female; D005602:France; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007258:Informed Consent; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D017257:Ramipril
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001643:Bridged Bicyclo Compounds; D001952:Bridged-Ring Compounds; D017257:Ramipril
Etude multicentrique ambulatoire du Triatec (ramipril). Réflexions concernant les enseignements de l'étude pour la réalisation d'essais futurs et pour la prise en charge des hypertendus.